Nohla Therapeutics is a cellular therapy company driven to provide leading off the shelf therapies for patients with critical diseases. Nohla’s first product is a universal donor cell therapy targeting hematopoietic recovery and chemotherapy induced neutropenia, and is being extended to treat a range of other medical indications. This and other products in the pipeline are based on a unique umbilical cord blood expansion platform developed at the Fred Hutchinson Cancer Research Center
Company Details
- Founded
- -
- Phone
- 1(206)519-5300
- in****@****ics.com
- Industry
- Biotechnology
- Website
- nohlatherapeutics.com
Nohla Therapeutics Questions
Nohla Therapeutics's helpline number is 1(206)519-5300
Nohla Therapeutics's website is nohlatherapeutics.com
Nohla Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nohla-therapeutics
Nohla Therapeutics's industry is
Biotechnology
Nohla Therapeutics's top competitors are
Faraday Pharmaceuticals, Inc.,
Outpace Bio,
Deverra Therapeutics,
Mozart Therapeutics, Inc.,
Umoja Biopharma,
Alpine Immune Sciences, Inc.,
Seagen,
Dendreon,
Sonoma Biotherapeutics, Inc.,
Coeptis, Inc.
Nohla Therapeutics's support email address is info@nohlatherapeutics.com
Nohla Therapeutics's categories are Biotechnology
Nohla Therapeutics's founding year is 2015
